109 related articles for article (PubMed ID: 23567329)
1. Investigation of the expression of mediators of neovascularization from mononuclear leukocytes in thromboangiitis obliterans.
Fazeli B; Rafatpanah H; Ravari H; Hosseini RF; Rezaee SA
Vascular; 2014 Jun; 22(3):174-80. PubMed ID: 23567329
[TBL] [Abstract][Full Text] [Related]
2. Sera of patients with thromboangiitis obliterans activated cultured human umbilical vein endothelial cells (HUVECs) and changed their adhesive properties.
Fazeli B; Rafatpanah H; Ravari H; Farid Hosseini R; Tavakol Afshari J; Hamidi Alamdari D; Valizadeh N; Moheghi N; Rezaee SA
Int J Rheum Dis; 2014 Jan; 17(1):106-12. PubMed ID: 24472273
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and antioxidative pathways might contribute to thromboangiitis obliterans pathophysiology.
Alamdari DH; Ravarit H; Tavallaie S; Fazeli B
Vascular; 2014 Feb; 22(1):46-50. PubMed ID: 23518834
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenic factors in patients with thromboangiitis obliterans.
Hewing B; Stangl V; Stangl K; Enke-Melzer K; Baumann G; Ludwig A
PLoS One; 2012; 7(4):e34717. PubMed ID: 22506045
[TBL] [Abstract][Full Text] [Related]
5. Imbalanced matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 activities in patients with thromboangiitis obliterans.
Dellalibera-Joviliano R; Jacob-Ferreira AL; Joviliano EE; Tanus-Santos JE; Evora PR
Vasc Med; 2012 Apr; 17(2):73-8. PubMed ID: 22402936
[TBL] [Abstract][Full Text] [Related]
6. Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients.
Dellalibera-Joviliano R; Joviliano EE; Silva JS; Evora PR
Clin Exp Immunol; 2012 Oct; 170(1):28-35. PubMed ID: 22943198
[TBL] [Abstract][Full Text] [Related]
7. Reduced circulating endothelial progenitor cells in thromboangiitis obliterans (Buerger's disease).
Park HS; Cho KH; Kim KL; Kim DK; Lee T
Vasc Med; 2013 Dec; 18(6):331-9. PubMed ID: 24292638
[TBL] [Abstract][Full Text] [Related]
8. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
Idei N; Nishioka K; Soga J; Hidaka T; Hata T; Fujii Y; Fujimura N; Maruhashi T; Mikami S; Teragawa H; Kihara Y; Noma K; Chayama K; Higashi Y
Hypertension; 2011 Jan; 57(1):70-8. PubMed ID: 21115876
[TBL] [Abstract][Full Text] [Related]
9. [The prevalence of hyperhomocysteinemia in thromboangiitis obliterans. Does homocysteine play a role pathogenetically?].
Stammler F; Diehm C; Hsu E; Stockinger K; Amendt K
Dtsch Med Wochenschr; 1996 Nov; 121(46):1417-23. PubMed ID: 8974873
[TBL] [Abstract][Full Text] [Related]
10. Genetic evaluation of the common variant of the endothelial nitric oxide synthase (Glu(298)->Brodmann M; Renner W; Seinost G; Pabst E; Stark G; Pilger E
Int Angiol; 2002 Jun; 21(2):169-72. PubMed ID: 12110779
[TBL] [Abstract][Full Text] [Related]
11. Determination of kininogens levels and kallikrein/kininase II activities in patients with thromboangiitis obliterans.
Dellalibera-Joviliano R; Joviliano EE; Evora PR
Scand J Immunol; 2010 Aug; 72(2):128-33. PubMed ID: 20618771
[TBL] [Abstract][Full Text] [Related]
12. Si-Miao-Yong-An Decoction alleviates thromboangiitis obliterans by regulating miR-548j-5p/IL-17A signaling pathway.
Chu C; Sun S; Zhang Z; Wu Q; Li H; Liang G; Miao X; Jiang H; Gao Y; Zhang Y; Wang B; Li X
Chin J Nat Med; 2024 Jun; 22(6):541-553. PubMed ID: 38906601
[TBL] [Abstract][Full Text] [Related]
13. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats.
Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X
J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting.
Taguchi A; Ohtani M; Soma T; Watanabe M; Kinosita N
Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):276-8. PubMed ID: 12623341
[No Abstract] [Full Text] [Related]
16. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
17. Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells.
Boon RA; Urbich C; Fischer A; Fontijn RD; Seeger FH; Koyanagi M; Horrevoets AJ; Dimmeler S
Eur Heart J; 2011 Feb; 32(3):371-7. PubMed ID: 20494899
[TBL] [Abstract][Full Text] [Related]
18. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells.
Rehman J; Li J; Parvathaneni L; Karlsson G; Panchal VR; Temm CJ; Mahenthiran J; March KL
J Am Coll Cardiol; 2004 Jun; 43(12):2314-8. PubMed ID: 15193699
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
Salven P; Hattori K; Heissig B; Rafii S
FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production in thromboangiitis obliterans patients: new evidence for an immune-mediated inflammatory disorder.
Slavov ES; Stanilova SA; Petkov DP; Dobreva ZG
Clin Exp Rheumatol; 2005; 23(2):219-26. PubMed ID: 15895893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
